Allworth Financial LP Travere Therapeutics, Inc. Transaction History
Allworth Financial LP
- $16.1 Billion
- Q3 2024
A detailed history of Allworth Financial LP transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Allworth Financial LP holds 568 shares of TVTX stock, worth $11,274. This represents 0.0% of its overall portfolio holdings.
Number of Shares
568
Previous 568
-0.0%
Holding current value
$11,274
Previous $4,000
75.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding TVTX
# of Institutions
187Shares Held
89.5MCall Options Held
137KPut Options Held
184K-
Black Rock Inc. New York, NY7.64MShares$152 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.5MShares$149 Million0.8% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.37MShares$146 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.62MShares$131 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.48MShares$89 Million1.14% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.27B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...